Immune system link with rare ovarian cancer could guide future treatment
Immune-related genes are associated with the development of the rare cancer ovarian clear cell carcinoma (OCCC), new research has found.
Oct 14, 2021
0
6
Immune-related genes are associated with the development of the rare cancer ovarian clear cell carcinoma (OCCC), new research has found.
Oct 14, 2021
0
6
A commentary by Mayo Clinic Cancer Center researchers published in the Journal of Clinical Oncology Practice suggests that advances in breast cancer prevention research have resulted in new and innovative opportunities to ...
Sep 27, 2021
0
2
Massachusetts General Hospital (MGH) researchers have identified for the first time how a highly aggressive form of breast cancer can evade one of the most powerful and effective drugs used to treat it, reporting their findings ...
Aug 17, 2021
0
325
Better treatments of HER2-positive breast cancer are closer at hand, thanks to new research by a team led by Université de Montréal professor Jean-François Côté at the cytoskeleton organization and cell-migration research ...
Jul 12, 2021
0
23
Notch proteins are key regulators of growth and differentiation of both normal and cancer cells. Researchers in Turku, Finland, have now demonstrated that the activities of distinct Notch family members are modified differently ...
Apr 22, 2021
0
12
Targeted therapy in early stages of breast cancer can pave the way for a notable higher success rate, shows a study from the University of Bergen, Norway (UiB).
Apr 20, 2021
0
5
A new study led by the University of Westminster shows that removing small genetic parts of our genomes called microRNAs from triple negative breast cancer cells can reverse its spread.
Feb 5, 2021
0
225
Scientists have revealed the molecular mechanism regulating the trafficking of lysosomes that increases the invasiveness of radioresistant cancer cells following radiotherapy.
Oct 29, 2020
0
0
Researchers from the Garvan Institute of Medical Research have uncovered four new subtypes of cells within triple negative breast cancer, which contain promising new therapeutic targets for the aggressive disease.
Aug 13, 2020
0
74
In a new multi-center study of U.S. women with newly diagnosed invasive breast cancer, Mount Sinai researchers have shown that insulin resistance is one factor mediating part of the association between race and poor prognosis ...
May 12, 2020
0
4